{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-25-000074","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.620425+00:00","generated_at":"2026-05-17T03:50:25.105105+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"confidence":"high","headline":"PetMed Express FY2025 net sales $227M, net loss $6.3M; Q1/Q2 filings delayed","bullets":["Net sales of $227.0M for FY2025 below preliminary range of $231.6M-$233.6M due to restatement of promotional sales reimbursements to cost of sales.","Net loss of $6.3M widened from preliminary estimated loss of $4.5M-$5.0M, driven by a $1.2M non-cash impairment charge for intangible assets.","Cash balance of $54.7M and no debt as of March 31, 2025.","Company filed Form 10-K; plans to file Q1 and Q2 2025 reports and resume normal quarterly earnings call cadence."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-25-000074","json":"https://secwatch.observer/filing/0001040130-25-000074.json","markdown":"https://secwatch.observer/filing/0001040130-25-000074.md","text":"https://secwatch.observer/filing/0001040130-25-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/0001040130-25-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/pets-20251014.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:50:25.105105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}